PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1533190
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1533190
The global label-free detection market is projected to reach USD 747 million by 2029 from USD 515 million in 2024, at a CAGR of 7.7% during the forecast period of 2024 to 2029. The growth of the Label-free detection market has been significantly driven by its increasing adoption among pharmaceutical and biotechnology companies for drug discovery application, increasing R&D investment by key players for the development and launch of innovative product and continuous advancements in label-free detection technologies. However, high instrument costs and the technical limitations of label-free detection are restraining market growth.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2029 |
Base Year | 2023 |
Forecast Period | 2024-2029 |
Units Considered | Value (USD Million) |
Segments | Offering, Technology, Application, and End User |
Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
"The biosensor chips segment under consumables segment accounted for the largest share by offering in 2023."
In 2023, the biosensor chips segment under consumables segment accounted for the largest share by offerings in the global label-free detection market. Biosensors are valuable instruments in the domains of biochemistry and biomedical engineering, as they offer a means of detecting a range of analytes. Label-free biosensors are currently popular in proteomics and biomolecular interaction research because the transducer can detect the chemical or biological agent without the need for dyes, enzymes, or radiolabels. Many tiny compounds are typically found via chromatographic techniques, which are typically expensive, large, and need specialized knowledge. Biosensors provide a quicker and less expensive option. Biosensors offer several benefits over traditional techniques for detecting tiny molecules, such as the ability to monitor in real-time, their high specificity, quick reaction times, minimal need for organic solvents and sample handling, portability, compact design, and simple operation.
"The US has continued to dominate the label-free detection market during the forecast period of 2024-2029."
The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Driven by the growing patient population suffering from infectious disease, increasing biopharmaceuticals' importance, and the necessity of safe and high-quality products in the healthcare sector, demand for label-free detection solutions is predicted to rise in the next years. Because of improved infrastructure, government assistance, and private financing, the country boasts a very developed R&D market. This advances creative and sophisticated research technologies. With label-free detection, which offers reduced turnaround time, and is energy-efficient and provides reliable results, with in a span of time, pharmaceutical companies in the US are actively collaborating in the creation of new reagent and test assays and using it. These elements help the global label-free detection industry to expand.
Danaher Corporation (US)
Sartorius AG (Germany)
Waters Corporation (US)
REVVITY, INC. (US)
Ametek, Inc. (US)
Horiba, Ltd. (Japan)
Spectris (UK)
Corning Incorporated (US)
Agilent Technologies, Inc. (US)
Shimadzu Corporation (Japan)
Hitachi High-Tech Corporation (Japan)
Attana AB (Sweden)
Bruker Corporation (US)
Bio-Rad Laboratories (US)
ENDRESS+HAUSER Group Services AG (Switzerland)
Becton, Dickinson and Company (US)
Nanotemper Technologies GmBH (Germany)
Affinite Instruments (Canada)
Biosensing Instrument (US)
Unchained Labs.(US)
BioNavis Ltd. (Finland)
Gator Bio (US)
Carterra, Inc. (US)
Nicoya Lifesciences Inc., (Canada)
BiOptix Analytical LLC (US)
Plexera Bioscience (US)
XanTec bioanalytics GmbH (Germany)
BMG Labtech (Germany)
RedShift BioAnalytics, Inc. (US)
lino Biotech AG (Switzerland)
This research report categorizes the label-free detection market by offering (Instruments, Consumables (Biosesor Chips, Microplates, Reagents & Kits), Software & Services), by Technology (Surface Plasmon Resonance, Differential Scanning Calorimetry, Bio-layer Interferometry, Isothermal Titration Calorimetry and Other Technologies), by Application (Binding Kinetics, Binding Thermodynamics, HIT Confirmation, Lead Generation, Endogenous Receptor Detection, and Other Application) by end user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organization, and Other End Users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Label-free detection market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Label-free detection market.
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall label-free detection market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.